Key result
Pulsatile growth hormone administration had the greatest effects on bone turnover markers and decreased CYP1A2 and CYP3A4 activities, whereas continuous infusion increased CYP3A4 activity.
Why the study?
Does the pattern of growth hormone administration affect metabolic and bone markers in GH-deficient adults?
Does the pattern of growth hormone administration affect metabolic and bone markers in GH-deficient adults?
Answers are grounded in this paper and cite their sources.
Growth hormone pulse pattern is an independent regulator of its metabolic actions in humans, potentially explaining gender differences in drug metabolism and growth rate.
The importance of gender-specific growth hormone (GH) secretion pattern in the regulation of growth and metabolism has been demonstrated clearly in rodents. We recently showed that GH secretion in humans is also sexually dimorphic. Whether GH secretion pattern regulates the metabolic effects of GH in humans is largely unknown. To address this question, we administered the same daily intravenous dose of GH (0.5 mg. m(-2). day(-1)) for 8 days in different patterns to nine GH-deficient adults. Each subject was studied on four occasions: protocol 1 (no treatment), protocol 2 (80% daily dose at 0100 and 10% daily dose at 0900 and 1700), protocol 3 (8 equal boluses every 3 h), and protocol 4 (continuous GH infusion). The effects of GH pattern on serum IGF-I, IGF-binding protein (IGFBP)-3, osteocalcin, and urine deoxypyridinoline were measured. Hepatic CYP1A2 and CYP3A4 activities were assessed by the caffeine and erythromycin breath tests, respectively. Protocols 3 and 4 were the most effective in increasing serum IGF-I and IGFBP-3, whereas protocols administering pulsatile GH had the greatest effects on markers of bone formation and resorption. All GH treatments decreased CYP1A2 activity, and the effect was greatest for pulsatile GH. Pulsatile GH decreased, whereas continuous GH infusion increased, CYP3A4 activity. These data demonstrate that GH pulse pattern is an independent parameter of GH action in humans. Gender differences in drug metabolism and, potentially, gender differences in growth rate may be explained by sex-specific GH secretion patterns.
No takes yet. Share an insight, caveat, or question.
Jaffe et al. (2002) studied GH deficiency (n=9). Growth hormone (GH) in different patterns vs. No treatment was evaluated on Serum IGF-I, IGFBP-3, osteocalcin, urine deoxypyridinoline, and hepatic CYP1A2 and CYP3A4 activities. Pulsatile growth hormone administration had the greatest effects on bone turnover markers and decreased CYP1A2 and CYP3A4 activities, whereas continuous infusion increased CYP3A4 activity.
Synapse has enriched 10 related papers. Consider them for comparative context: